|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 26, 2018 ) The "Global Digital Genome Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global digital genome market with detailed market segmentation by product, application, end-user, and geography. The global digital genome market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The digital genome market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increase in technological evolution, growing awareness of genetic roles in diagnosis of genetic disorders such as cancer, diabetes and attention deficit hyperactivity disorder. The increasing public-private investments, funds, and grants is the primary factor which is driving the growth of digital genome market. On other hand the growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth.
Get Sample PDF of Advanced Information Brochure@ http://bit.ly/2J6sHaD
The global digital genome market is segmented on the basis of product, application, and end user. The digital genome market is segmented into DNA/RNA analysis kits, sequencing chips, sequencing & analyzer instruments, sample prep instruments and sequencing & analysis software, by product. On the basis of application segment, the digital genome market is classified into diagnostics, agricultural, academic research, drug discovery, personalizes medicine, and other applications. Based on end users, the digital genome market is categorized into diagnostics & forensic labs, academic research institutes, hospitals and others.
Leading Market Players:
1. Thermo Fisher Scientific Inc.
2. QIAGEN
3. GenomeMe
4. Umbel
5. BiogeniQ Inc.
6. F. Hoffmann-La Roche Ltd
7. NanoString Technologies, Inc.
8. Illumina, Inc.
9. BD
10. bioMérieux SA
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global digital genome market based on product, application, and end user. It also provides market size and forecast till 2025 for overall digital genome market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting digital genome market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key digital genome manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Thermo Fisher Scientific Inc., QIAGEN, GenomeMe, Umbel, BiogeniQ Inc., F. Hoffmann-La Roche Ltd, NanoString Technologies, Inc., Illumina, Inc., BD, bioMérieux SA and among others.
Check Discount for this Report @ http://bit.ly/2JbAbtf
The Insight Partners
Sameer Joshi
+1-646-491-9876
sam@theinsightpartners.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
